drugset / Trial / NCT00097357
BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to learn if BMS-562247 can prevent blood clots in the legs and lungs in men and women following unilateral total knee replacement surgery. The safety of this treatment will also be studied.
Timeline
- Start
- 2004-10
- Primary completion
- 2005-12
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Apixaban | Small molecule | 2.5 mg | Oral |
| Subject | Apixaban | Small molecule | 5 mg | Oral |
| Subject | Apixaban | Small molecule | 10 mg | Oral |
| Subject | Apixaban | Small molecule | 20 mg | Oral |
| Comparator | Enoxaparin sodium | Other / unclassified | 30 mg | Subcutaneous |
| Comparator | Warfarin | Small molecule | 5 mg | Oral |